The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...
Eli Lilly announces positive results from phase 3 ACHIEVE-2 & ACHIEVE-5 trials of orforglipron versus dapagliflozin in adults with type 2 diabetes: Indianapolis Thursday, October ...
Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...
Zacks.com on MSN
LLY's Oral GLP-1 Pill Scores Another Pair of Diabetes Wins
Eli Lilly's oral GLP-1 pill orforglipron delivers strong A1C reductions in two late-stage diabetes studies, reinforcing its ...
In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee ...
In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by ...
Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data ...
Eli Lilly and Company's strong Phase 3 diabetes drug results boost its GLP-1 franchise. Click for my updated look at LLY ...
The proportion of participants achieving HbA1c < 7.0% and a =10% reduction in body weight from baseline was 48.0% in the mazdutide group and 21.0% in the semaglutide ...
Eli Lilly (LLY) stock is in focus as the company's oral weight loss candidate orforglipron succeeds in two Phase 3 trials for ...
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 ...
There are 5 MG Electric cars currently available for sale at starting price Rs 7.50 Lakh Lakh. The most popular MG Electric cars are MG Windsor EV (Rs. 12.65 - 18.39 Lakh), MG Cyberster (Rs. 75 Lakh), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback